Enhanced gene expression in epithelial cells transfected with amino acid-substituted gemini nanoparticles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 75, Issue 3, 2010, Pages 311-320

  Yang, Peng ^a   Singh, Jagbir ^a   Wettig, Shawn ^b   Foldvari, Marianna ^b   Verrall, Ronald E ^a   Badea, Ildiko ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Delivery efficiency; Epithelial cells; Gene therapy; In vitro transfection; Nanoparticles; Non viral

Indexed keywords

ALKYL GROUP; DIPEPTIDE; DNA; GAMMA INTERFERON; GLYCINE; GREEN FLUORESCENT PROTEIN; LIPID; LYSINE; NANOPARTICLE; PHOSPHATIDYLETHANOLAMINE; PLASMID DNA; SURFACTANT;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CIRCULAR DICHROISM; COMPLEX FORMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; QUANTITATIVE ANALYSIS; SYNTHESIS; ZETA POTENTIAL;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CIRCULAR DICHROISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; MAGNETIC RESONANCE SPECTROSCOPY; NANOPARTICLES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TRANSFECTION;

EID: 77954541460     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.04.007     Document Type: Article

References (30)

1. Freundlich B., Jimenez S.A., Steen V.D., Medsger T.A., Szkolnicki M., Jaffe H.S. Treatment of systemic sclerosis with recombinant interferon-gamma. A phase i/ii clinical trial. Arthritis Rheum. 1992, 35:1134-1142.
2. Buys L.M. Treatment options for atopic dermatitis. Am. Fam. Physician 2007, 75:523-528.
3. Emmez H., Kardes O., Dogulu F., Kurt G., Memis L., Baykaner M.K. Role of antifibrotic cytokine interferon-gamma in the prevention of postlaminectomy peridural fibrosis in rats. Neurosurgery 2008, 62:1351-1357. (discussion 7-8).
4. Menger F.M., Keiper J.S. Gemini surfactants. Angew. Chem. Int. Ed. Engl. 2000, 39:1906-1920.
5. Badea I., Verrall R., Baca-Estrada M., et al. In vivo cutaneous interferon-gamma gene delivery using novel dicationic (gemini) surfactant-plasmid complexes. J. Gene Med. 2005, 7:1200-1214.
6. Fielden M.L., Perrin C., Kremer A., et al. Sugar-based tertiary amino gemini surfactants with a vesicle-to-micelle transition in the endosomal ph range mediate efficient transfection in vitro. Eur. J. Biochem. 2001, 268:1269-1279.
7. Rosenzweig H.S., Rakhmanova V.A., MacDonald R.C. Diquaternary ammonium compounds as transfection agents. Bioconjugate Chem. 2001, 12:258-263.
8. Wettig S.D., Badea I., Donkuru M., Verrall R.E., Foldvari M. Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles. J. Gene Med. 2007, 9:649-658.
9. Fisicaro E., Compari C., Duce E., Donofrio G., Rozycka-Roszak B., Wozniak E. Biologically active bisquaternary ammonium chlorides: physico-chemical properties of long chain amphiphiles and their evaluation as non-viral vectors for gene delivery. Biochim. Biophys. Acta 2005, 1722:224-233.
10. Zana R. Dimeric (gemini) surfactants: effect of the spacer group on the association behavior in aqueous solution. J. Colloid Interf. Sci. 2002, 248:203-220.
11. Karlsson L., van Eijk M., Soderman O. Compaction of DNA by gemini surfactants: effects of surfactant architecture. J. Colloid Interf. Sci. 2002, 252:290-296.
12. Wang C., Li X., Wettig S.D., Badea I., Foldvari M., Verrall R.E. Investigation of complexes formed by interaction of cationic gemini surfactants with deoxyribonucleic acid. Phys. Chem. Chem. Phys. 2007, 9:1616-1628.
13. Foldvari M., Badea I., Wettig S., Verrall R., Bagonluri M. Structural characterization of novel gemini non-viral DNA delivery systems for cutaneous gene therapy. J. Exp. Nanosci. 2006, 1:165-176.
14. Kharidia R., Friedman K.A., Liang J.F. Improved gene expression using low molecular weight peptides produced from protamine sulfate. Biochemistry (Mosc.) 2008, 73:1162-1168.
15. Wettig S.D., Verrall R.E. Thermodynamic studies of aqueous m-s-m gemini surfactant systems. J. Colloid Interf. Sci. 2001, 235:310-316.
16. Zakharian T.Y., Seryshev A., Sitharaman B., Gilbert B.E., Knight V., Wilson L.J. A fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture. J. Am. Chem. Soc. 2005, 127:12508-12509.
17. Li X., Wettig S.D., Wang C., Foldvari M., Verrall R.E. Synthesis and solution properties of gemini surfactants containing oleyl chains. Phys. Chem. Chem. Phys. 2005, 7:3172-3178.
18. Carpena P., Aguiar J., Bernaola-Galvan P., Ruiz C.C. Problems associated with the treatment of conductivity-concentration data in surfactant solutions: simulations and experiments. Langmuir 2002, 18:6054-6058.
19. Jiang N., Li P.X., Wang Y.L., Wang J.B., Yan H.K., Thomas R.K. Aggregation behavior of hexadecyltrimethylammonium surfactants with various counterions in aqueous solution. J. Colloid Interf. Sci. 2005, 286:755-760.
20. Alami E., Beinert G., Marie P., Zana R. Alkanediyl-alpha, omega-bis(dimethylalkylammonium bromide) surfactants. 3. Behavior at the air-water-interface. Langmuir 1993, 9:1465-1467.
21. Chen X., Wang J., Shen N., et al. Gemini surfactant/DNA complex monolayers at the air-water interface: effect of surfactant structure on the assembly, stability, and topography of monolayers. Langmuir 2002, 18:6222-6228.
22. Pathak A., Aggarwal A., Kurupati R.K., et al. Engineered polyallylamine nanoparticles for efficient in vitro transfection. Pharm. Res. 2007, 24:1427-1440.
23. Mislick K.A., Baldeschwieler J.D. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. USA 1996, 93:12349-12354.
24. Jabbari E. Targeted delivery with peptidomimetic conjugated self-assembled nanoparticles. Pharm. Res. 2009, 26:612-630.
25. Colombo G., Soto P., Gazit E. Peptide self-assembly at the nanoscale: a challenging target for computational and experimental biotechnology. Trends Biotechnol. 2007, 25:211-218.
26. Almofti M.R., Harashima H., Shinohara Y., Almofti A., Baba Y., Kiwada H. Cationic liposome-mediated gene delivery: biophysical study and mechanism of internalization. Arch. Biochem. Biophys. 2003, 410:246-253.
27. Mehnert W., Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 2001, 47:165-196.
28. Badea I., Wettig S., Verrall R., Foldvari M. Topical non-invasive gene delivery using gemini nanoparticles in interferon-gamma-deficient mice. Eur. J. Pharm. Biopharm. 2007, 65:414-422.
29. Simberg D., Danino D., Talmon Y., et al. Phase behavior, DNA ordering, and size instability of cationic lipoplexes. Relevance to optimal transfection activity. J. Biol. Chem. 2001, 276:47453-47459.
30. Braun C.S., Jas G.S., Choosakoonkriang S., Koe G.S., Smith J.G., Middaugh C.R. The structure of DNA within cationic lipid/DNA complexes. Biophys. J. 2003, 84:1114-1123.